Advertisement
Advertisement
CNTA
Centessa Pharmaceuticals plc - ADR
39.48
USDSponsored
-0.28
-0.70%
Apr 10, 15:59 UTC -4
Closed
After-Market
39.55
+0.07
+0.17%
CNTA Earnings Reports
Positive Surprise Ratio
CNTA beat 11 of 19 last estimates.
58%
Next Report
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.40
Implied change from Q4 25 (Revenue/ EPS)
--
/-16.67%
Implied change from Q1 25 (Revenue/ EPS)
-100.00%
/+100.00%
Centessa Pharmaceuticals plc - ADR earnings per share and revenue
On Mar 31, 2026, CNTA reported earnings of -0.48 USD per share (EPS) for Q4 25, missing the estimate of -0.38 USD, resulting in a -23.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.52% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an decrease of -16.67% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AleAnna, Inc. Class A Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-Actual
$0.00
Surprise
-
Lexeo Therapeutics, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.27
Surprise
+15.84%
Unicycive Therapeutics, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.48
Actual
-$0.81
Surprise
-69.64%
Cardiol Therapeutics Inc. Class A Common Shares
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.07
Surprise
+14.22%
Galectin Therapeutics Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.08
Surprise
+21.57%
Actinium Pharmaceuticals, Inc
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-5.04%
Scienture Holdings, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.28
Actual
-$0.11
Surprise
+61.48%
Jupiter Neurosciences, Inc. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.06
Surprise
+6.16%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$2.32
Actual
-$2.34
Surprise
-0.62%
Galmed Pharmaceuticals Ltd.
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.52
Actual
-$0.80
Surprise
-53.79%
FAQ
What were Centessa Pharmaceuticals plc - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Centessa Pharmaceuticals plc - ADR reported EPS of -$0.48, missing estimates by -23.58%, and revenue of $0.00, 0% as expectations.
How did the market react to Centessa Pharmaceuticals plc - ADR's Q4 2025 earnings?
The stock price moved up 7.52%, changed from $25.94 before the earnings release to $27.89 the day after.
When is Centessa Pharmaceuticals plc - ADR expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Centessa Pharmaceuticals plc - ADR's next earnings report?
Based on 8
analysts, Centessa Pharmaceuticals plc - ADR is expected to report EPS of -$0.40 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement